NCT04410367 - Study to Establish Image Interpretation Criteria for 18F Fluciclovine PET in Detecting Recurrent Brain Metastases (PURSUE) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions

Brain Metastases

Interventions

DRUG

18F fluciclovine

18F fluciclovine injection, 185 MegaBecquerel (MBq) (5 Millicurie (mCi)) ± 20%, delivered as an intravenous bolus

Trial Locations (9)

NYU Langone Health, New York

University of Pennsylvania Health System, Philadelphia

Miami Cancer Institute, Miami

University Hospital Cleveland, Cleveland

Washington University School of Medicine Center for Clinical Imaging Research, St Louis

Ochsner Clinic Foundation, New Orleans

Center for Quantitative Cancer Imaging at Huntsman Cancer Institute, Salt Lake City

John Wayne Cancer Institute at Providence St. John's Health Center, Santa Monica

Yale School of Medicine, New Haven